Article Name Predictive Diagnostics
DrSeq IRD panel includes 850 genes and thousands of known and novel variants, providing superior diagnostic accuracy
10th September, 2024
Fast Track designation can fill unmet medical needs for patients suffering from Osteoarthritis
06th September, 2024
Enhanced functionality for the storage and administration of highly sensitive ophthalmic drugs
02nd September, 2024
Ease of use, higher efficiency and lower risk of disease transmission in surgical applications
23rd August, 2024
A controlled and effective release of drugs via ‘Nikkomycin’ polymeric nanoparticles
20th August, 2024
Study to focus on ability of implants to grow natural breast tissue and completely degrade over time
19th August, 2024
Easy-to-use, affordable, and cost-effective dressing with an integrated pump
19th August, 2024
First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic
18th August, 2024
Reducing the need for animal testing in fields such as regenerative medicine and drug discovery
15th August, 2024
Protein biomarkers-based rapid result within minutes
13th August, 2024
Potential hemostatic solution to reduce blood loss, disability, and mortality during surgery and trauma care
12th August, 2024
To advance understanding of genetic architecture and diversity of Singapore’s multi-ethnic population
04th August, 2024
Pattern Discovery Engine platform identifies enables development of synergistic drug combinations against multifactorial diseases
31st July, 2024
Outlines the financial terms for implementing the activities of the WHO Global Traditional Medicine Centre (GTMC) in Gujarat
01st August, 2024
The Indian pathology market has emerged as a critical component of the country's healthcare ecosystem, driven by the increasing prevalence of chronic diseases, infections, and lifestyle-related health problems. As the demand for precise and prompt diagnosis rises, the importance of pathology services has never been more pronounced. Let's delve into the market landscape, segmentation, global and Indian test prices, types of tests, and pathology equipment base, painting a comprehensive picture of the Indian pathology market.
01st August, 2024
Blockchain For Impact (BFI), established during the second wave of the COVID-19 pandemic in India, is continuing its trailblazing journey after announcing a monumental allocation of $15 million through its BFI-BIOME Virtual Network Program, aimed at propelling biomedical research forward in India. In the past three months, BFI has already allocated a substantial amount through strategic MoU’s with elite research institutes and incubators, setting in motion its plans to revolutionise biomedical research and innovation in the country. BioSpectrum India spoke to Sandeep Nailwal, Founder of BFI, in detail about his vision for driving transformative change in the healthcare landscape.
01st August, 2024
A safe and effective option for healthcare professionals and patients
24th July, 2024
New NURA health screening centre opens in Ulaanbaatar
24th July, 2024
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer